Volume 51, Number 10, 1761-1764, DOI: 10.1007/s00125-008-1115-8

Published in partnership with the

Logo

European Association for the Study of Diabetes

Can patients with type 2 diabetes be treated with 5′-AMP-activated protein kinase activators?

W. W. Winder

View Related Documents

Abstract

Keywords  AICAR - 5′-AMP-activated protein kinase - AMPK activators - Fatty acid turnover - Gluconeogenesis - Glucoregulation - Hepatic glucose production - Type 2 diabetes

Fulltext Preview

Image of the first page of the fulltext document